Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition
New England Journal of Medicine · 07.11.2026
DOI: 10.1056/nejmc2611265 ↗Kurz gefasst
Leserbrief in der Zeitschrift New England Journal of Medicine, online erschienen am 07.11.2026. Verfasst von Morris J Brown und 10 weiteren Autor:innen. Beteiligte Einrichtung: Queen Mary University of London, London. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Queen Mary University of London, London.
- University of Michigan, Ann Arbor.
- University of California, San Francisco, San Francisco.
- Ohio State University Wexner Medical Center, Columbus.
- University of Texas Southwestern Medical Center, Dallas.
- Cedars-Sinai Health Sciences University, Los Angeles.
ORCID-Profile: Morris J Brown
Zitieren
APA
Brown, M. J., Turcu, A. F., Sam, R., Kirschner, L. S., Hamidi, O., Eren, A., Ben-Shlomo, A., Huang, W., Bancos, I., Hamrahian, A. H., & Freeman, M. W. (2026). Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition. New England Journal of Medicine. https://doi.org/10.1056/nejmc2611265
Vancouver
Brown MJ, Turcu AF, Sam R, Kirschner LS, Hamidi O, Eren A, et al. Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition. New England Journal of Medicine. 2026. doi:10.1056/nejmc2611265
BibTeX
@article{Brown2026,
author = {Brown, Morris J and Turcu, Adina F and Sam, Ramin and Kirschner, Lawrence S and Hamidi, Oksana and Eren, Aysegul and Ben-Shlomo, Anat and Huang, Wenyu and Bancos, Irina and Hamrahian, Amir H and Freeman, Mason W},
title = {Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition},
journal = {New England Journal of Medicine},
year = {2026},
doi = {10.1056/nejmc2611265}
}
EUVIMED